Jerrold H. Levy

40.2k total citations · 14 hit papers
472 papers, 23.6k citations indexed

About

Jerrold H. Levy is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Jerrold H. Levy has authored 472 papers receiving a total of 23.6k indexed citations (citations by other indexed papers that have themselves been cited), including 174 papers in Cardiology and Cardiovascular Medicine, 157 papers in Surgery and 135 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Jerrold H. Levy's work include Trauma, Hemostasis, Coagulopathy, Resuscitation (125 papers), Venous Thromboembolism Diagnosis and Management (114 papers) and Blood transfusion and management (86 papers). Jerrold H. Levy is often cited by papers focused on Trauma, Hemostasis, Coagulopathy, Resuscitation (125 papers), Venous Thromboembolism Diagnosis and Management (114 papers) and Blood transfusion and management (86 papers). Jerrold H. Levy collaborates with scholars based in United States, Japan and Canada. Jerrold H. Levy's co-authors include Toshiaki Iba, Jean M. Connors, Marcel Levi, Jecko Thachil, Kenichi A. Tanaka, Fania Szlam, Lawrence T. Goodnough, Ian J. Welsby, Theodore E. Warkentin and Jeffrey I. Weitz and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Jerrold H. Levy

456 papers receiving 22.9k citations

Hit Papers

COVID-19 and its implicat... 2010 2026 2015 2020 2020 2020 2015 2019 2020 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. COVID-19 and its implications for thrombosis and anticoagulation
    2020 1.6k citations Jean M. Connors, Jerrold H. Levy profile →
  2. Coagulation abnormalities and thrombosis in patients with COVID-19
    2020 1.0k citations Marcel Levi, Jecko Thachil et al. profile →
  3. Idarucizumab for Dabigatran Reversal
    2015 981 citations Jerrold H. Levy, Jeffrey I. Weitz et al. profile →
  4. Guidelines for Perioperative Care in Cardiac Surgery
    2019 630 citations Jerrold H. Levy et al. profile →
  5. Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID‐19
    2020 440 citations Alex C. Spyropoulos, Jerrold H. Levy et al. Journal of Thrombosis and Haemostasis profile →
  6. Safety of Recombinant Activated Factor VII in Randomized Clinical Trials
    2010 432 citations Marcel Levi, Jerrold H. Levy et al. profile →
  7. Coagulopathy in COVID‐19
    2020 384 citations Toshiaki Iba, Jerrold H. Levy et al. Journal of Thrombosis and Haemostasis profile →
  8. Coagulopathy of Coronavirus Disease 2019
    2020 352 citations Toshiaki Iba, Jerrold H. Levy et al. profile →
  9. Inflammation and thrombosis: roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis
    2017 348 citations Toshiaki Iba, Jerrold H. Levy Journal of Thrombosis and Haemostasis profile →
  10. Diagnosis and management of sepsis‐induced coagulopathy and disseminated intravascular coagulation
    2019 330 citations Toshiaki Iba, Jerrold H. Levy et al. Journal of Thrombosis and Haemostasis profile →
  11. The unique characteristics of COVID-19 coagulopathy
    2020 329 citations Toshiaki Iba, Jerrold H. Levy et al. profile →
  12. New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey
    2017 249 citations Toshiaki Iba, Jerrold H. Levy et al. profile →
  13. Perioperative Management of Antithrombotic Therapy
    2022 146 citations James D. Douketis, Alex C. Spyropoulos et al. profile →
  14. The pathophysiology, diagnosis, and management of sepsis-associated disseminated intravascular coagulation
    2023 63 citations Toshiaki Iba, Julie Helms et al. Journal of Intensive Care profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Jerrold H. Levy 6.8k 6.2k 4.9k 4.6k 4.4k 472 23.6k
Marcel Levi 6.6k 1.0× 6.6k 1.1× 6.4k 1.3× 7.7k 1.7× 6.3k 1.4× 526 38.8k
Beverley J. Hunt 3.4k 0.5× 4.7k 0.8× 4.4k 0.9× 4.5k 1.0× 1.2k 0.3× 340 19.3k
Hugo Ten Cate 5.6k 0.8× 3.3k 0.5× 1.5k 0.3× 5.5k 1.2× 1.5k 0.3× 568 21.5k
Mark Crowther 19.7k 2.9× 10.3k 1.7× 2.5k 0.5× 21.4k 4.6× 1.1k 0.2× 584 40.0k
Ernest E. Moore 2.4k 0.3× 24.4k 3.9× 13.0k 2.7× 1.9k 0.4× 1.2k 0.3× 1.1k 49.9k
Bernd Jilma 4.8k 0.7× 2.4k 0.4× 729 0.1× 2.1k 0.5× 1.5k 0.3× 562 16.7k
Lawrence T. Goodnough 2.3k 0.3× 3.3k 0.5× 4.6k 0.9× 1.4k 0.3× 357 0.1× 305 20.6k
Sam Schulman 21.5k 3.1× 7.1k 1.2× 999 0.2× 21.5k 4.7× 953 0.2× 501 34.5k
Harry R. Büller 18.6k 2.7× 8.6k 1.4× 1.8k 0.4× 24.6k 5.3× 716 0.2× 450 35.7k
Theodore E. Warkentin 5.3k 0.8× 18.7k 3.0× 607 0.1× 11.7k 2.5× 1.5k 0.3× 326 25.1k

Countries citing papers authored by Jerrold H. Levy

Since Specialization
Citations

This map shows the geographic impact of Jerrold H. Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerrold H. Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerrold H. Levy more than expected).

Fields of papers citing papers by Jerrold H. Levy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerrold H. Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerrold H. Levy. The network helps show where Jerrold H. Levy may publish in the future.

Co-authorship network of co-authors of Jerrold H. Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Jerrold H. Levy. A scholar is included among the top collaborators of Jerrold H. Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerrold H. Levy. Jerrold H. Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iba, Toshiaki, Julie Helms, Isao Nagaoka, Ricard Ferrer, & Jerrold H. Levy. (2025). Heat stress-induced mitochondrial damage and its impact on leukocyte function. Journal of Intensive Care. 13(1). 61–61.
2.
Gouin‐Thibault, Isabelle, Jean M. Connors, Michaël Hardy, et al.. (2025). Results of an international survey on the management of therapeutic intensity unfractionated heparin: communication from the SSCs of the ISTH. Journal of Thrombosis and Haemostasis. 23(5). 1717–1726.
3.
Levy, Jerrold H., Peta Alexander, Alisa S. Wolberg, et al.. (2025). ECMO-induced coagulopathy: strategic initiatives for research and clinical practice (a workshop report of the NHLBI). PubMed. 2(2). 100064–100064. 3 indexed citations
4.
Umemura, Yutaka, Ecaterina Scărlătescu, Theresa Ukamaka Nwagha, et al.. (2025). Mortality, diagnosis, and etiology of disseminated intravascular coagulation—a systematic review and meta-analysis: communication from the ISTH SSC subcommittee on disseminated intravascular coagulation. Journal of Thrombosis and Haemostasis. 23(8). 2663–2679. 1 indexed citations
5.
Levy, Jerrold H., Joseph R. Shaw, Kamrouz Ghadimi, et al.. (2025). Perioperative use of factor concentrates and blood products—a survey of clinical practices in the United States: communication from the ISTH Subcommittee on Perioperative and Critical Care. Journal of Thrombosis and Haemostasis. 23(12). 3871–3882.
6.
Dias, João D., Jerrold H. Levy, Kenichi A. Tanaka, Kai Zacharowski, & Jan Hartmann. (2024). Viscoelastic haemostatic assays to guide therapy in elective surgery: an updated systematic review and meta‐analysis. Anaesthesia. 80(1). 95–103. 1 indexed citations
7.
Iba, Toshiaki, Jerrold H. Levy, Cheryl L. Maier, Jean M. Connors, & Marcel Levi. (2024). Four years into the pandemic, managing COVID-19 patients with acute coagulopathy: what have we learned?. Journal of Thrombosis and Haemostasis. 22(6). 1541–1549. 9 indexed citations
8.
Mishima, Y., et al.. (2024). Antithrombin supplementation attenuates heparin resistance in plasma spiked with Gla-domainless factor Xa S195A in vitro. British Journal of Anaesthesia. 132(6). 1204–1210. 4 indexed citations
9.
Levy, Jerrold H., Joseph R. Shaw, Lana A. Castellucci, et al.. (2024). Reversal of direct oral anticoagulants: guidance from the SSC of the ISTH. Journal of Thrombosis and Haemostasis. 22(10). 2889–2899. 17 indexed citations
10.
Iba, Toshiaki, Jerrold H. Levy, Jecko Thachil, et al.. (2023). Communication from the Scientific Standardization Committees of the International Society on Thrombosis and Haemostasis on vascular endothelium-related biomarkers in disseminated intravascular coagulation. Journal of Thrombosis and Haemostasis. 21(3). 691–699. 20 indexed citations
11.
Iba, Toshiaki, Jean M. Connors, & Jerrold H. Levy. (2023). What Role Does Microthrombosis Play in Long COVID?. Seminars in Thrombosis and Hemostasis. 50(4). 527–536. 9 indexed citations
12.
Levy, Jerrold H., Roman M. Sniecinski, Bianca Rocca, et al.. (2023). Defining heparin resistance: communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thrombosis and Hemostasis. Journal of Thrombosis and Haemostasis. 21(12). 3649–3657. 15 indexed citations
13.
Iba, Toshiaki, Julie Helms, Jean M. Connors, & Jerrold H. Levy. (2023). The pathophysiology, diagnosis, and management of sepsis-associated disseminated intravascular coagulation. Journal of Intensive Care. 11(1). 24–24. 63 indexed citations breakdown →
14.
Ghadimi, Kamrouz, Mary Cooter, Jerrold H. Levy, et al.. (2023). Inhaled Epoprostenol Compared With Nitric Oxide for Right Ventricular Support After Major Cardiac Surgery. Circulation. 148(17). 1316–1329. 11 indexed citations
15.
Schulman, Sam, Michelle Sholzberg, Alex C. Spyropoulos, et al.. (2022). ISTH guidelines for antithrombotic treatment in COVID‐19. Journal of Thrombosis and Haemostasis. 20(10). 2214–2225. 91 indexed citations
16.
Mazzeffi, Michael, Lucas H. Ting, Maxwell A. Hockstein, et al.. (2022). In Vitro Treatment of Extracorporeal Membrane Oxygenation Coagulopathy with Recombinant von Willebrand Factor or Lyophilized Platelets. Journal of Cardiothoracic and Vascular Anesthesia. 37(4). 522–527. 5 indexed citations
17.
Hardy, Michaël, Jonathan Douxfils, Stéphanie Roullet, et al.. (2021). Viscoelastometric Testing to Assess Hemostasis of COVID-19: A Systematic Review. Journal of Clinical Medicine. 10(8). 1740–1740. 42 indexed citations
18.
Wang, Tzu‐Fei, Robert S. Makar, Darko Antić, et al.. (2020). Management of hemostatic complications in acute leukemia: Guidance from the SSC of the ISTH. Journal of Thrombosis and Haemostasis. 18(12). 3174–3183. 19 indexed citations
19.
20.
Thachil, Jecko, Nicole P. Juffermans, Marco Ranucci, et al.. (2020). ISTH DIC subcommittee communication on anticoagulation in COVID‐19. Journal of Thrombosis and Haemostasis. 18(9). 2138–2144. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marcel Levi Breakdown of academic impact, for papers by Beverley J. Hunt Breakdown of academic impact, for papers by Hugo Ten Cate Breakdown of academic impact, for papers by Mark Crowther Breakdown of academic impact, for papers by Ernest E. Moore Breakdown of academic impact, for papers by Bernd Jilma Breakdown of academic impact, for papers by Lawrence T. Goodnough Breakdown of academic impact, for papers by Sam Schulman Breakdown of academic impact, for papers by Harry R. Büller Breakdown of academic impact, for papers by Theodore E. Warkentin
Rankless by CCL
2026